# Zambia Chlorhexidine Application Trial

> **NCT01241318** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston University** · enrollment: 77535 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Chlorhexidine gluconate (4%)
- **PROCEDURE:** Dry cord care

## Key facts

- **NCT ID:** NCT01241318
- **Lead sponsor:** Boston University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 77535 (ACTUAL)
- **Last updated:** 2020-08-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241318, "Zambia Chlorhexidine Application Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01241318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*